In 2006 the pharmaceutical industry will seek opportunities to acquire foreign inflection point – foreign investment, mergers and acquisitions, pharmaceutical – pharmaceutical industry

Massive publicity materials, bustling sea of people Promotions Tactics, held in Zhengzhou, the 55th National Drugs Fair, nearly 20 million people come to Zhengzhou, the widespread habit of "Yao Wei", in which the back is "the whole Medicine Sell In a semi-stagnation, "a Pharmaceutical Industry Official told reporters that the circle of their knowledge of several characters have a lot of weight to rest at home.

  State Food and Drug Administration on the people at the fair said that the current situation in the entire pharmaceutical industry, an unprecedented grim daily average of two production companies and three distribution companies, "dead." Chinese Medicine Center for Economic Research, Principal Consultant, Hubei Medical Group Board of Kyushu through the Deputy Secretary-General that the cow is dry, this year will be the turning point of the pharmaceutical industry, the next two years will lay Capital The best time to enter.

Three difficulties Experts believe that the current problems facing enterprises are mainly three: the cost of difficulties. China Medical Business Association Executive Vice President Zhu Changhao said the past two years, the overall cost of the pharmaceutical industry continued to be elevated in: raw materials, energy, transport and so the price increases circulation, GMP transformation caused a substantial increase in fixed costs and so on.

Second, R & D dilemma. Henan Fu Jen Pharmaceutical Group Chairman Zhu Wenchen that the lack of innovation in China's environment, pharmaceutical companies, who lose money who engage in creative, innovative risk is very large, but even if approved drugs down may not be able to recover input, according to domestic policy, new drugs hard into the health insurance directory, into the directory can not be difficult to have a market size.

The third is the market predicament. Representatives of a foreign pharmaceutical company told reporters: Unlike other countries, 80%% drugs need to Hospital Sales. Because the policy, hospitals in the drug purchase price plus 15%% on the smooth as its profits. In order to obtain more profit hospital, trying to use your medicine, opened a large prescription. The more real good efficacy, low price, consumers can bear Drugs are , Even if difficult to achieve successful large volume sales.

Integration or death Drug prices Sustained decline was also the inevitable trend of 2006, the 18th price cuts are expected in turn began. Zhuchang Hao said that, in fact, 17 times over the past eight consecutive years resulted in lower prices overall profits of pharmaceutical companies fell sharply, the overall company entered the marginal profit. Beijing Feng Tong Group

Kyushu Bureau of Traditional Chinese Medicine Co., Ltd. Deputy General Manager of the city is dry that the cows: the industry returns in the apparent decline, the chain will force the pharmaceutical industry for all aspects of change, in order to promote "the whole industry chain of Traditional Chinese Medicine efficiency ", it certainly will eliminate some inefficient sectors and enterprises.

"Domestic thousands of businesses, small and weak to survive it must find a patron." Li Xi, a senior industry expert said light. Worked in the foreign large-scale pharmaceutical enterprises, said Li Xi-guang, foreign companies interested in the domestic pharmaceutical industry is the production line and train terminal acquisitions team, as well as some specific products.

Policy calls for industry consolidation Dongsheng Chinese limited liability company to the rapid expansion of mergers and acquisitions, and the company's deputy general manager of Guan Ping in the acceptance of the "Shanghai Securities News" interview that will stop the merger Dongsheng the next few years, focusing on integration of enterprise internal resources.

Guan Ping told reporters that the confusion is now the industry's largest pharmaceutical industry lacked Steel , Car-industry policy, not the whole Planning So that companies can not conduct according to the development of integrated industrial chain. And a number of departments, various management documents, policies often allow companies rushed deal. [Key words]: Foreign investment   M   Medicine Comment Large   In   Small

I am an expert from decorative-wall-panel.com, usually analyzes all kind of industries situation, while decorative-wall-panel.com provides the latest news, industry report and quality product, such as china Marble texture , china Tile texture decorative wall panel manufacturer

Processing your request, Please wait....

Leave a Reply